The Medical journal of Australia
-
To investigate associations between sociodemographic factors, pre-existing chronic comorbidities, and general practitioner-led diagnosis of long COVID. ⋯ Female sex, middle age, high socio-economic status and pre-existing comorbidities, including mental health conditions, respiratory conditions, cancer and musculoskeletal conditions, were associated with general practitioner-led long COVID diagnosis among general practice patients. These factors largely parallel the emerging international evidence on long COVID and highlight the patient characteristics that practitioners should be cognisant of when patients present with symptoms of long COVID.
-
To determine the impact of persistent symptoms after coronavirus disease 2019 (COVID-19) in an Australian population. ⋯ Persistent symptoms after COVID-19 are common, though with a lower incidence following infection from less virulent strains. Although long COVID can be largely managed in primary care, a minority of people who have persistent symptoms and impaired function may require specialist care pathways, the effectiveness of which should be a focus of future research.
-
The economic burden of long COVID in Australia during 2022 was $1.7 billion to $6.3 billion representing 0.07%-0.26% of GDP.
pearl -
Skinner T, Brown A, Teixeira-Pinto A, et al. Sensitivity and specificity of Aboriginal-developed items to supplement the adapted PHQ-9 screening measure for depression: results from the Getting it Right study. Med J Aust 2024; https://doi.org/10.5694/mja2.52406 In this research article, the fourth author's name was spelt incorrectly as Sara F Farnbach. The correct spelling is Sara Farnbach.